US/JAPAN COORDINATORS AND PRINCIPAL ADVISORS
| Etiology Program Area | ||
| Coordinators: | Dr. Richard H. Adamson, National Cancer Institute Dr. Takashi Sugimura, National Cancer Center |
|
| Advisors: | 1. Carcinogenesis | Dr. Masaaki Terada, National Cancer Center Research Institute |
| 2. Human Tumor Virus | Dr. Kumao Toyoshima, University of Osaka | |
| 3. Oncogene | Dr. Susumu Nishimura, National Cancer Center | |
| Biology and Diagnosis Program Area | ||
| Coordinators: | Dr. Richard J. Hodes, National Cancer Institute Dr. Toshiyuki Hamaoka, Osaka University Advisors |
|
| Advisors: | 1. Immunology | Dr. Toshiyuki Hamaoka, Osaka University |
| 2. Diagnosis | Dr. Kumao Toyoshima, Osaka University | |
| 3. Cellular Biology | Dr. Tadatsugu Taniguchi, Osaka University | |
Treatment Program Area |
||
| Coordinators: | Dr. Michael A. Friedman, National Cancer Institute Dr. Makoto Ogawa, Aichi Cancer Center Hospital |
|
| Advisors: | 1. Radiotherapy | Dr. Mitsuyuki Abe, Kyoto University |
| 2. Immunotherapy | Dr. Yoshiyuki Hashimoto, Tohoku University | |
| 3. Chemotherapy | Dr. Takashi Tsuruo, University of Tokyo | |
| 4. Surgery | Dr. Toshifumi Nakajima, Japanese Foundation for Cancer Research | |
Interdisciplinary Program Area |
||
| Coordinators: | Dr. Robert W. Miller, National Cancer Institute Dr. Haruo Sugano, Japanese Foundation for Cancer Research |
|
| Advisors: | 1. Epidemiology | Dr. Kunio, Aoki Aichi Cancer Center |
| 2. Pathology | Dr. Tomoyuki Kitagawa, Japanese Foundation for Cancer Research | |